These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 2437709

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Central nervous system catecholamine metabolism in Korsakoff's psychosis.
    Martin PR, Weingartner H, Gordon EK, Burns RS, Linnoila M, Kopin IJ, Ebert MH.
    Ann Neurol; 1984 Feb; 15(2):184-7. PubMed ID: 6200058
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neurochemical pathology in Korsakoff's psychosis: implications for other cognitive disorders.
    McEntee WJ, Mair RG, Langlais PJ.
    Neurology; 1984 May; 34(5):648-52. PubMed ID: 6200802
    [Abstract] [Full Text] [Related]

  • 5. Memory impairment in Korsakoff's psychosis: a correlation with brain noradrenergic activity.
    McEntee WJ, Mair RG.
    Science; 1978 Nov 24; 202(4370):905-7. PubMed ID: 715450
    [Abstract] [Full Text] [Related]

  • 6. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K.
    No To Shinkei; 1982 Nov 24; 34(11):1099-106. PubMed ID: 6186264
    [Abstract] [Full Text] [Related]

  • 7. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis.
    Markianos M, Koutsis G, Evangelopoulos ME, Mandellos D, Karahalios G, Sfagos C.
    J Neurochem; 2009 Jan 24; 108(1):158-64. PubMed ID: 19014375
    [Abstract] [Full Text] [Related]

  • 8. Multimodal sensory discrimination deficits in Korsakoff's psychosis.
    Mair RG, Doty RL, Kelly KM, Wilson CS, Langlais PJ, McEntee WJ, Vollmecke TA.
    Neuropsychologia; 1986 Jan 24; 24(6):831-9. PubMed ID: 2433640
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
    Eklundh T, Eriksson M, Sjöberg S, Nordin C.
    J Psychiatr Res; 1996 Jan 24; 30(3):201-8. PubMed ID: 8884658
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK, Nordin C, Jönsson EG, Engberg G, Linderholm KR, Erhardt S.
    J Psychiatr Res; 2007 Jan 24; 41(1-2):144-51. PubMed ID: 16434056
    [Abstract] [Full Text] [Related]

  • 13. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE, Foxx JL, Butler IJ.
    Ann Neurol; 1980 Jul 24; 8(1):38-42. PubMed ID: 6157351
    [Abstract] [Full Text] [Related]

  • 14. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S.
    Biol Psychiatry; 1983 Oct 24; 18(10):1141-52. PubMed ID: 6197099
    [Abstract] [Full Text] [Related]

  • 15. A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index.
    Ducci F, Newman TK, Funt S, Brown GL, Virkkunen M, Goldman D.
    Mol Psychiatry; 2006 Sep 24; 11(9):858-66. PubMed ID: 16770335
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW, Ebert MH, van Kammen DP, Post RM, Goodwin FK.
    Biol Psychiatry; 1983 Nov 24; 18(11):1287-99. PubMed ID: 6197100
    [Abstract] [Full Text] [Related]

  • 18. Multiple motor learning experiences enhance motor adaptability.
    Seidler RD.
    J Cogn Neurosci; 2004 Nov 24; 16(1):65-73. PubMed ID: 15006037
    [Abstract] [Full Text] [Related]

  • 19. CSF neurotransmitter metabolites and neuropsychiatric symptomatology in patients with normal pressure hydrocephalus.
    Markianos M, Lafazanos S, Koutsis G, Sfagos C, Seretis A.
    Clin Neurol Neurosurg; 2009 Apr 24; 111(3):231-4. PubMed ID: 19046799
    [Abstract] [Full Text] [Related]

  • 20. Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia.
    Oades RD, Klimke A, Henning U, Rao ML.
    Hum Psychopharmacol; 2002 Jan 24; 17(1):15-27. PubMed ID: 12404703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.